Cargando…
Isoliquiritigenin Inhibits Atherosclerosis by Blocking TRPC5 Channel Expression
Isoliquiritigenin (ISL) is a flavonoid isolated mainly from the licorice plant, a traditional Chinese herb. ISL has shown anticancer, anti-inflammatory, antioxidant, and antidiabetic activities. However, the pharmaceutical effects of ISL on atherosclerosis are seldom explored. In this study, we used...
Autores principales: | Qi, Jie, Cui, Jianguo, Mi, Baobin, Yan, Xiaohong, Xu, Wenwen, Ma, Hui, Zhang, Qingtan, Xu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7166290/ https://www.ncbi.nlm.nih.gov/pubmed/32328171 http://dx.doi.org/10.1155/2020/1926249 |
Ejemplares similares
-
miR-26a inhibits atherosclerosis progression by targeting TRPC3
por: Feng, Min, et al.
Publicado: (2018) -
Corticolimbic Expression of TRPC4 and TRPC5 Channels in the Rodent Brain
por: Fowler, Melissa A., et al.
Publicado: (2007) -
TRPC Channels in Cardiac Plasticity
por: Numaga-Tomita, Takuro, et al.
Publicado: (2020) -
TRPC Channels in the SOCE Scenario
por: Lopez, Jose J., et al.
Publicado: (2020) -
Nitric oxide lacks direct effect on TRPC5 channels but suppresses endogenous TRPC5-containing channels in endothelial cells
por: Wong, Ching-On, et al.
Publicado: (2010)